Induction of S-phase entry by E2F transcription factors depends on their nuclear localization - PubMed (original) (raw)
Induction of S-phase entry by E2F transcription factors depends on their nuclear localization
H Müller et al. Mol Cell Biol. 1997 Sep.
Abstract
The E2F transcription factors are essential for regulating the correct timing of activation of several genes whose products are implicated in cell proliferation and DNA replication. The E2Fs are targets for negative regulation by the retinoblastoma protein family, which includes pRB, p107, and p130, and they are in a pathway that is frequently found altered in human cancers. There are five members of the E2F family, and they can be divided into two functional subgroups. Whereas, upon overexpression, E2F-1, -2, and -3 induce S phase in quiescent fibroblasts and override G1 arrests mediated by the p16INK4A tumor suppressor protein or neutralizing antibodies to cyclin D1, E2F-4 and -5 do not. Using E2F-1 and E2F-4 as representatives of the two subgroups, we showed here, by constructing a set of chimeric proteins, that the amino terminus of E2F-1 is sufficient to confer S-phase-inducing potential as well as the ability to efficiently transactivate an E2F-responsive promoter to E2F-4. We found that the E2F-1 amino terminus directs chimeric proteins to the nucleus. Surprisingly, a short nuclear localization signal derived from simian virus 40 large T antigen could perfectly substitute for the presence of the E2F-1 amino terminus in these assays. Thus, nuclearly localized E2F-4, when overexpressed, displayed biological activities similar to those of E2F-1. Furthermore, we showed that nuclear localization of endogenous E2F-4 is cell cycle regulated, with E2F-4 being nuclear in the G0 and early G1 phases and mainly cytoplasmic after the pRB family members have become phosphorylated. We propose a novel mechanism for the regulation of E2F-dependent transcription in which E2F-4 regulates transcription only from G0 until mid- to late G1 phase whereas E2F-1 is active in late G1 and S phases, until it is inactivated by cyclin A-dependent kinase in late S phase.
Similar articles
- Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression.
Lukas J, Petersen BO, Holm K, Bartek J, Helin K. Lukas J, et al. Mol Cell Biol. 1996 Mar;16(3):1047-57. doi: 10.1128/MCB.16.3.1047. Mol Cell Biol. 1996. PMID: 8622649 Free PMC article. - E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
Mann DJ, Jones NC. Mann DJ, et al. Curr Biol. 1996 Apr 1;6(4):474-83. doi: 10.1016/s0960-9822(02)00515-8. Curr Biol. 1996. PMID: 8723352 - The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB, Rutka JT, Hubbard SL, Mondal S, Hamel PA. Dirks PB, et al. Oncogene. 1998 Aug 20;17(7):867-76. doi: 10.1038/sj.onc.1202008. Oncogene. 1998. PMID: 9780003 - Regulation of the G1/S transition phase in mesangial cells by E2F1.
Inoshita S, Terada Y, Nakashima O, Kuwahara M, Sasaki S, Marumo F. Inoshita S, et al. Kidney Int. 1999 Oct;56(4):1238-41. doi: 10.1046/j.1523-1755.1999.00705.x. Kidney Int. 1999. PMID: 10504464 Review. - The cellular effects of E2F overexpression.
Adams PD, Kaelin WG Jr. Adams PD, et al. Curr Top Microbiol Immunol. 1996;208:79-93. doi: 10.1007/978-3-642-79910-5_4. Curr Top Microbiol Immunol. 1996. PMID: 8575214 Review.
Cited by
- In vivo CRISPR/Cas9-mediated screen reveals a critical function of TFDP1 and E2F4 transcription factors in hematopoiesis.
Tran NT, Graf R, Acevedo-Ochoa E, Trombke J, Weber T, Sommermann T, Salomon C, Kühn R, Rajewsky K, Chu VT. Tran NT, et al. Leukemia. 2024 Sep;38(9):2003-2015. doi: 10.1038/s41375-024-02357-w. Epub 2024 Jul 23. Leukemia. 2024. PMID: 39043964 Free PMC article. - The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy.
Pathania AS, Chava H, Balusu R, Pasupulati AK, Coulter DW, Challagundla KB. Pathania AS, et al. Mol Ther Oncol. 2024 Feb 29;32(2):200785. doi: 10.1016/j.omton.2024.200785. eCollection 2024 Jun 20. Mol Ther Oncol. 2024. PMID: 38595981 Free PMC article. Review. - Revealing role of epigenetic modifiers and DNA oxidation in cell-autonomous regulation of Cancer stem cells.
Ferrer-Diaz AI, Sinha G, Petryna A, Gonzalez-Bermejo R, Kenfack Y, Adetayo O, Patel SA, Hooda-Nehra A, Rameshwar P. Ferrer-Diaz AI, et al. Cell Commun Signal. 2024 Feb 12;22(1):119. doi: 10.1186/s12964-024-01512-1. Cell Commun Signal. 2024. PMID: 38347590 Free PMC article. - Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression.
Zhou Y, Nakajima R, Shirasawa M, Fikriyanti M, Zhao L, Iwanaga R, Bradford AP, Kurayoshi K, Araki K, Ohtani K. Zhou Y, et al. Biology (Basel). 2023 Dec 11;12(12):1511. doi: 10.3390/biology12121511. Biology (Basel). 2023. PMID: 38132337 Free PMC article. Review. - Merkel cell polyomavirus large T antigen binding to pRb promotes skin hyperplasia and tumor development.
Spurgeon ME, Cheng J, Ward-Shaw E, Dick FA, DeCaprio JA, Lambert PF. Spurgeon ME, et al. PLoS Pathog. 2022 May 13;18(5):e1010551. doi: 10.1371/journal.ppat.1010551. eCollection 2022 May. PLoS Pathog. 2022. PMID: 35560034 Free PMC article.
References
- Genes Dev. 1994 Nov 15;8(22):2680-90 - PubMed
- Genes Dev. 1994 Aug 1;8(15):1772-86 - PubMed
- Oncogene. 1995 Jan 5;10(1):39-48 - PubMed
- Cell. 1995 May 5;81(3):323-30 - PubMed
- Mol Cell Biol. 1995 May;15(5):2600-11 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials